Citation·page:ea-biosecurity-scope:fn19

Is EA Biosecurity Work Limited to Restricting LLM Biological Use? - Footnote 19

Verdictpartial90%

1 check · 4/3/2026

The source does not specify the year the seed round was raised. The claim states it was in 2025, which is not verifiable from the source. The source states that Red Queen Bio spun out of HelixNano, not HelixNano (clinical-stage mRNA therapeutics).

Our claim

entire record

No record data available.

Source evidence

1 src · 1 check

www.redqueen.bio/

partial90%Haiku 4.5 · 4/3/2026

NoteThe source does not specify the year the seed round was raised. The claim states it was in 2025, which is not verifiable from the source. The source states that Red Queen Bio spun out of HelixNano, not HelixNano (clinical-stage mRNA therapeutics).

Case № page:ea-biosecurity-scope:fn19Filed 4/3/2026Confidence 90%